跳至主要内容
临床试验/EUCTR2011-004465-32-DK
EUCTR2011-004465-32-DK进行中(未招募)1 期

Can post-operative treatment with parathyroid hormone enhance bone healing and quality of newly formed bone after sternotomy in cardiac surgery patients? - PATH 2011

Dept. of Cardiothoracic & Vascular Surgery, Aarhus University Hospital, Skejby0 个研究点目标入组 24 人开始时间: 2011年11月17日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Male

入选标准

  • Men 50 years of age or more
  • Full sternotomy
  • Not in chronic, systemic corticosteroid treatment.
  • No Plavix treatment 5 days prior to surgery
  • No known bone metabolic diseases.
  • Normal serum levels of Vitamin D, Calcium, PTH, alkaline phosphatase (within reference interval).
  • No known risk of osteosarcoma.
  • Ability to understand and cooperate with the planned examinations.
  • Ability to speak and understand Danish.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 24
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 24

排除标准

  • Re-operation
  • Use of bonewax during surgery
  • Prior radiation therapy involving the skeleton
  • Severely impaired renal function
  • Known allergic reactions to any of the compounds in the trial medication.
  • Current treatment with digoxin
  • Major medical or social problems that will be likely to preclude participation
  • Severely impaired liver function
  • Unknown raised levels of bone specific alkaline phosphatase

研究者

发起方
Dept. of Cardiothoracic & Vascular Surgery, Aarhus University Hospital, Skejby

相似试验